IE 11 is not supported. For an optimal experience visit our site on another browser.
  • UP NEXT

    Holiday package theft on the rise as porch pirate warning issued

    04:08
  • Streaming bundles points to future of subscription services

    04:23
  • What is behind Elon Musk’s recent divisive nature?

    04:40
  • How artificial intelligence can pick out holiday gifts for you

    03:56
  • Third-party candidates aim to disrupt Biden-Trump rematch in 2024

    04:36
  • New drugs revolutionizing weight-loss and health care

    04:34
  • Meta denies claim its business model maximizes kids’ screen time

    05:15
  • Homebuyers spooked by rising interest rates, cooling market

    04:16
  • Kevin McCarthy ousted as speaker: What happens next?

    04:35
  • Immigration system under strain after latest surge at the border

    04:34
  • Inside the manhunt of an escaped convict that captivated a nation

    03:35
  • FDA expected to approve new COVID booster as cases rise in US

    04:31
  • Homeowners face insurance woes amid rise in natural disasters

    04:58
  • Maui locals face effort to rebuild three weeks after deadly wildfires

    04:42
  • Tuohy family plans to end conservatorship of Michael Oher

    04:33
  • What’s behind the increased shark sightings this summer?

    04:42
  • Inside the economic power of Taylor Swift

    05:00
  • Hollywood faces uncertain future amid SAG-AFTRA, WGA strikes

    04:51
  • New health warnings after hottest days on Earth recorded

    04:17
  • What’s next after Supreme Court’s college affirmative action ruling?

    04:39

Experimental Alzheimer’s drug shows promising results in patients

04:38

An experimental drug for Alzheimer's was found to reduce cognitive decline in patients significantly, offering a potential breakthrough against the devastating disease. NBC’s Maggie Vespa reports in this week’s Sunday Focus on the risks and how soon the drug might be available.

Chris Hemsworth on learning about his Alzheimer’s risk: ‘It became a wonderful motivator’